Condition: Prostate Cancer (Adenocarcinoma) · Low and Intermediate Risk Prostate Cancer · Sponsor: University Health Network, Toronto
This clinical research study is intended to show that Micro-Ultrasound Guided Focal Laser Ablation (MicroUSgFLA) is a safe procedure that can significantly postpone or eliminate the need for patients with intermediate-Risk prostate cancer (PCa) to undergo a definitive treatment (i.e., Radical Prostatectomy or Radiation Therapy) for their disease.
This description comes directly from the study's public registry record.
Kateri Corr · 416-946-4501 · kateri.corr@uhn.ca
Sangeet Ghai, MD · 416-340-4656 · sangeet.ghai@uhn.ca
Always discuss trial participation with your own doctor first.
| University Health Network - Princess Margaret Cancer Centre | Toronto, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07339943